ES342172A1 - Pharmaceutical Compositions Containing Alkaloids. - Google Patents
Pharmaceutical Compositions Containing Alkaloids.Info
- Publication number
- ES342172A1 ES342172A1 ES342172A ES342172A ES342172A1 ES 342172 A1 ES342172 A1 ES 342172A1 ES 342172 A ES342172 A ES 342172A ES 342172 A ES342172 A ES 342172A ES 342172 A1 ES342172 A1 ES 342172A1
- Authority
- ES
- Spain
- Prior art keywords
- water
- physiologically tolerable
- pharmaceutical compositions
- compositions containing
- soluble physiologically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229930013930 alkaloid Natural products 0.000 title 1
- 150000003839 salts Chemical class 0.000 abstract 3
- 239000000203 mixture Substances 0.000 abstract 2
- XQYZDYMELSJDRZ-UHFFFAOYSA-N papaverine Chemical compound C1=C(OC)C(OC)=CC=C1CC1=NC=CC2=CC(OC)=C(OC)C=C12 XQYZDYMELSJDRZ-UHFFFAOYSA-N 0.000 abstract 2
- 229930008281 A03AD01 - Papaverine Natural products 0.000 abstract 1
- 229930008564 C01BA04 - Sparteine Natural products 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- SLRCCWJSBJZJBV-UHFFFAOYSA-N alpha-isosparteine Natural products C1N2CCCCC2C2CN3CCCCC3C1C2 SLRCCWJSBJZJBV-UHFFFAOYSA-N 0.000 abstract 1
- 230000017531 blood circulation Effects 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- PBUNVLRHZGSROC-VTIMJTGVSA-N dihydro-alpha-ergocryptine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C(=O)N[C@]3(C(=O)N4[C@H](C(N5CCC[C@H]5[C@]4(O)O3)=O)CC(C)C)C(C)C)=C3C2=CNC3=C1 PBUNVLRHZGSROC-VTIMJTGVSA-N 0.000 abstract 1
- SEALOBQTUQIVGU-QNIJNHAOSA-N dihydroergocornine Chemical compound C1=CC([C@H]2C[C@H](CN(C)[C@@H]2C2)C(=O)N[C@]3(C(=O)N4[C@H](C(N5CCC[C@H]5[C@]4(O)O3)=O)C(C)C)C(C)C)=C3C2=CNC3=C1 SEALOBQTUQIVGU-QNIJNHAOSA-N 0.000 abstract 1
- 229960004290 dihydroergocornine Drugs 0.000 abstract 1
- 229960002032 dihydroergocryptine Drugs 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 229960001789 papaverine Drugs 0.000 abstract 1
- SLRCCWJSBJZJBV-AJNGGQMLSA-N sparteine Chemical compound C1N2CCCC[C@H]2[C@@H]2CN3CCCC[C@H]3[C@H]1C2 SLRCCWJSBJZJBV-AJNGGQMLSA-N 0.000 abstract 1
- 229960001945 sparteine Drugs 0.000 abstract 1
- 230000001256 tonic effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/485—Morphinan derivatives, e.g. morphine, codeine
Landscapes
- Health & Medical Sciences (AREA)
- Emergency Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
A pharmaceutical composition incorporates a combination consisting of (i) at least one of dihydroergoeristine, dihydroergocryptine, dihydroergocornine or their water-soluble physiologically tolerable salts, (ii) papaverine or a water-soluble physiologically tolerable salt thereof and (iii) sparteine or a water-soluble physiologically tolerable salt thereof. The composition may also contain known diluents, carriers and additives. The composition is stated to improve blood circulation and to have a tonic effect.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR66851A FR5468M (en) | 1966-06-24 | 1966-06-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES342172A1 true ES342172A1 (en) | 1968-10-01 |
Family
ID=8611745
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES342172A Expired ES342172A1 (en) | 1966-06-24 | 1967-06-22 | Pharmaceutical Compositions Containing Alkaloids. |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE700371A (en) |
| ES (1) | ES342172A1 (en) |
| FR (1) | FR5468M (en) |
| GB (1) | GB1180120A (en) |
| MX (1) | MX3493E (en) |
| NL (1) | NL6708490A (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4153700A (en) * | 1975-08-27 | 1979-05-08 | Lake Shore Roentgenology Ltd. | Treatment of the acute after-effects resulting from alcohol ingestion |
| IT1157365B (en) * | 1977-10-24 | 1987-02-11 | Sandoz Ag | MEDICATIONS TO TREAT OBESITY OR REDUCE BODY WEIGHT |
| HU192050B (en) * | 1983-04-22 | 1987-05-28 | Sandoz Ag | Process for production of medical preparative containing co-dergocrin and one piridin-dicarbonic acid diesthertype calcium-antagonist |
| YU183988A (en) * | 1988-09-30 | 1990-08-31 | Lek Tovarna Farmacevtskih | Process for preparing dispersion pills of dihydroergotoxine |
-
1966
- 1966-06-24 FR FR66851A patent/FR5468M/fr not_active Expired
-
1967
- 1967-06-09 GB GB2675267A patent/GB1180120A/en not_active Expired
- 1967-06-19 NL NL6708490A patent/NL6708490A/xx unknown
- 1967-06-22 MX MX10022667U patent/MX3493E/en unknown
- 1967-06-22 BE BE700371D patent/BE700371A/xx not_active IP Right Cessation
- 1967-06-22 ES ES342172A patent/ES342172A1/en not_active Expired
Also Published As
| Publication number | Publication date |
|---|---|
| FR5468M (en) | 1967-10-16 |
| NL6708490A (en) | 1967-12-27 |
| GB1180120A (en) | 1970-02-04 |
| BE700371A (en) | 1967-12-22 |
| MX3493E (en) | 1980-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE8402549D0 (en) | SUBSTITUTED MORANOLINE DERIVATIVES | |
| ES412387A1 (en) | Formulation for oral administration of penicillins having improved taste properties | |
| ES425514A1 (en) | Coumarin derivatives for the treatment of allergies | |
| ES342172A1 (en) | Pharmaceutical Compositions Containing Alkaloids. | |
| GB1268951A (en) | Phenoxy-amines | |
| ES434431A1 (en) | PROCEDURE FOR PREPARING XANTHENE DERIVATIVES. | |
| ES454085A1 (en) | Procedure for the preparation of N- (r-tetrahydrofurfuril) -noroximorphone and N- (s-tetrahydrofurfuril) -noroximorphone new. (Machine-translation by Google Translate, not legally binding) | |
| ES368955A1 (en) | Procedure for preparing substitute guanidines. (Machine-translation by Google Translate, not legally binding) | |
| GB1270049A (en) | New pharmaceutical product | |
| GB1350878A (en) | Coumarin derivatives and production thereof | |
| GB1332697A (en) | Benzodiazepine derivatives | |
| ES430676A1 (en) | 2-Substituted -1,2,4-thiadiazolo-(2,3-a)benzimidazoles and process for their preparation | |
| GB1449404A (en) | N-arylsulphonyl urea derivatives | |
| FR2092785A1 (en) | 2-azaquinolizidine derivs and salts neurotropic and anti - -histamine agents synthesis | |
| GB1297890A (en) | ||
| GB1342643A (en) | Thioacetanilide derivatives | |
| GB1359044A (en) | Quinoline derivatives | |
| GB1169990A (en) | Phenoxy Propan-2-Olamines | |
| GB1340535A (en) | Benzodiazepine derivatives | |
| ES346192A1 (en) | 6-chloro-2-(5-nitro-2-furyl) cinchoninic acid | |
| ES335966A1 (en) | A PROCEDURE FOR THE PREPARATION OF BENZO-DIACEPINE DERIVATIVES. | |
| GB1250209A (en) | ||
| ES294928A1 (en) | A procedure to prepare a liquid and stable composition of tetracycline (Machine-translation by Google Translate, not legally binding) | |
| ES428823A1 (en) | PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF ADENOSINADISTITUTED IN N (6). | |
| GB1269001A (en) | 6- or 7-methoxyisoquinolines |